Mauna Kea Technologies SA (0P5I.L)
| Previous close | 0.3890 |
| Open | 0.3895 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.3895 - 0.3895 |
| 52-week range | 0.3895 - 0.7630 |
| Volume | |
| Avg. volume | 442 |
| Market cap | 119,565 |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3530 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Mauna Kea Technologies Reports Full Year 2023 Results and Q1 2024 Sales
PARIS & BOSTON, April 25, 2024--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today reported its financial results for the full year 2023 and its sales for the first quarter 2024.
- Business Wire
Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank
PARIS & BOSTON, April 24, 2024--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) (Paris:ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the execution of an agreement to restructure €21.3 million in outstanding debt obligations related to the Company’s finance contract with the European Investment Bank (EIB).
- Business Wire
Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
PARIS, April 04, 2024--Regulatory News: Mauna Kea Technologies (Paris:ALMKT):
